Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia
Work
Year: 2024
Type: article
Abstract: Background Benralizumab is indicated as add-on therapy in patients with uncontrolled, severe eosinophilic asthma; it has not yet been evaluated in a large Asian population with asthma in a clinical tr... more
Source: Respiratory Medicine
Institutions First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Inner Mongolia People's Hospital, Ruijin Hospital +4 more
Cites: 24
Cited by: 1
Related to: 10
FWCI: 1.313
Citation percentile (by year/subfield): 78.56
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: hybrid
APC paid (est): $3,420
Funder AstraZeneca